Treatment of septic shock complicated by mediastinitis after HeartMate 3 BiVAD implantation using echo-guided device parameter optimization: a case report
Authors/Creators
- 1. Department of Cardiac Surgery, St. Ekaterina University Hospital, Sofia, Bulgaria
- 2. Department of Anesthesiology and Intensive Care, St. Ekaterina University Hospital, Sofia, Bulgaria
- 3. Department of Cardiology, St. Ekaterina University Hospital, Sofia, Bulgaria
- 4. Department of Clinical Microbiology, St. Ekaterina University Hospital, Sofia, Bulgaria
Description
Introduction: Septic shock complicated by poststernotomy mediastinitis in patients with mechanical circulatory support devices is a rare and life-threatening condition associated with high mortality. Management is particularly challenging because of the presence of prosthetic material and the risk of device contamination.
Case presentation: We report a 63-year-old man with end-stage nonischemic cardiomyopathy who underwent HeartMate 3 biventricular assist device (BiVAD) implantation as bridge-to-transplant therapy. Four weeks after discharge, he was readmitted with septic shock, multiorgan failure, and mediastinitis. Treatment included broad-spectrum empirical antimicrobial therapy followed by targeted de-escalation, repeated surgical debridement with prolonged vacuum-assisted closure (VAC) therapy, continuous renal replacement therapy, and individualized echocardiography-guided optimization of BiVAD pump parameters to improve systemic perfusion. Device explantation was avoided. During rehabilitation, orthostatic collapse due to posture-dependent preload insufficiency was diagnosed using upright transesophageal echocardiography and resolved through targeted pump flow adjustment.
Conclusion: This case demonstrates that severe septic shock and mediastinitis in BiVAD-supported patients can be successfully managed without device removal through multidisciplinary care, antimicrobial stewardship, VAC therapy, and dynamic echocardiography-guided device optimization.
Files
PHAR_article_184514.pdf
Files
(2.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:47baee0cff7aa986f336862e43538ba4
|
2.4 MB | Preview Download |
|
md5:4a202ea3c8cea878ab455ba512132859
|
32.6 kB | Preview Download |
Additional details
References
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent J-L, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315: 801–810. https://doi.org/10.1001/jama.2016.0287
- Singh K, Anderson E, Harper JG (2011) Overview and Management of Sternal Wound Infection. Seminars in Plastic Surgery 25: 025–033. https://doi.org/10.1055/s-0031-1275168
- Sun Q, Jian J, Zhou X, Hong Z, Yang S, Zheng Y, Wang S, Zhao M (2025) Population pharmacokinetics of teicoplanin and dosage optimization in sepsis patients based on continuous renal replacement therapy. Frontiers in Pharmacology 16: 1621959. https://doi.org/10.3389/fphar.2025.1621959
- Thalhammer F, Schenk P, Burgmann H, El Menyawi I, Hollenstein UM, Rosenkranz AR, Sunder-Plassmann G, Breyer S, Ratheiser K (1998) Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Antimicrobial Agents and Chemotherapy 42: 2417–2420. https://doi.org/10.1128/AAC.42.9.2417